Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32642
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMortazavi, Zahra Sadat-
dc.contributor.authorZandifar, Alireza-
dc.contributor.authorUb Kim, Jorge Du-
dc.contributor.authorTierradentro-García, Luis Octavio-
dc.contributor.authorShakarami, Mehrnaz-
dc.contributor.authorZamharir, Farzam Dashti-
dc.contributor.authorHadipour, Maryam-
dc.contributor.authorOustad, Marjan-
dc.contributor.authorShafiei, Elham-
dc.contributor.authorTara, Seyedeh Zahra-
dc.contributor.authorShirani, Peyman-
dc.contributor.authorAsadi, Hamed-
dc.contributor.authorVossough, Arastoo-
dc.contributor.authorSaadatnia, Mohammad-
dc.date2023-
dc.date.accessioned2023-04-14T02:47:28Z-
dc.date.available2023-04-14T02:47:28Z-
dc.date.issued2023-07-
dc.identifier.citationWorld Neurosurgery 2023; 175en_US
dc.identifier.issn1878-8769-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/32642-
dc.description.abstractSubarachnoid hemorrhage (SAH) is one of the world's most life-threatening types of stroke. SAH can be classified into two main categories, aneurysmal (aSAH) and non-aneurysmal SAH (naSAH). In the present study, we aimed to prospectively evaluate SAH and its subcategories incidences, risk factors (RF), complications and outcomes in central Iran. All SAH patients diagnosed between 2016-2020 were included in Isfahan SAH Registry (ISR). Demographic, clinical characteristics, incidence rates (based on age categories), and laboratory/imaging findings were collected and compared between aSAH and naSAH subgroups. Complications during hospital stay and outcomes were also analyzed. Binary logistic regression analysis was performed to investigate the predictors of aSAH versus naSAH. Kaplan-Meier curves and Cox regression were used to evaluate the survival probability. A total of 461 SAH patients were included through ISR. The SAH annual incidence rate was 3.11 per 100,000 person-years. aSAH had higher incidence rate than naSAH (2.08/100,000 versus 0.9/100,00 person-years). In-hospital mortality was 18.2% with no significant difference between aSAH and naSAH subgroups. Hypertension (p=0.003) and smoking (p=0.03) were significantly associated with aSAH, whereas DM (p<0.001) was more associated with naSAH. After Cox regression analysis, there were higher hazard ratios for reduced in-hospital survival in conditions including altered mental status, Glasgow coma scale ≤13, rebleeding and seizures. This study provided an updated estimation of SAH and its subgroups incidences in central Iran. Risk factors for aSAH are comparable to the ones reported in the literature. It is noteworthy that DM was associated with a higher incidence of naSAH in our cohort.en_US
dc.language.isoeng-
dc.titleRe-evaluating Risk Factors, Incidence, and Outcome of Aneurysmal and Non-aneurysmal Subarachnoid Hemorrhage: A Population-based Registry Study from Isfahan Province, Iran, 2016-2020.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleWorld Neurosurgeryen_US
dc.identifier.affiliationIsfahan Neurosciences Research Center, Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran; Isfahan Medical Student Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.en_US
dc.identifier.affiliationDepartment of Radiology, Division of Neuroradiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.en_US
dc.identifier.affiliationHealth Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.en_US
dc.identifier.affiliationDepartment of Neurology, Bushehr University of Medical Sciences, Kangan, Iran.en_US
dc.identifier.affiliationNon-Communicable Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.en_US
dc.identifier.affiliationDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.en_US
dc.identifier.affiliationDepartments of Neurology and Neurosurgery, University of Cincinnati Medical Center, Cincinnati, OH, USA.en_US
dc.identifier.affiliationSchool of Medicine-Faculty of Health, Deakin University, Waurn Ponds, Victoria, Australia; Interventional Neuroradiology Unit, Monash Imaging, Monash Health, Clayton, Victoria, Australia; Department of Interventional Radiology, St Vincent's Health Australia, Fitzroy, Victoria, Australia; Stroke Division, Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Radiology, Division of Neuroradiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.en_US
dc.identifier.affiliationIsfahan Neurosciences Research Center, Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran.en_US
dc.identifier.affiliationRadiologyen_US
dc.identifier.doi10.1016/j.wneu.2023.03.131en_US
dc.type.contentTexten_US
dc.identifier.pubmedid37024083-
local.name.researcherAsadi, Hamed
item.languageiso639-1en-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
crisitem.author.deptRadiology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

36
checked on Nov 8, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.